|
| |
XRCC1
Gene Information from Publications |
| Publication Link |
Summary of findings |
| 17849423 |
Arg399Gln polymorphism is associated with increased frequency of p53 mutations in codon 249 among the Guangxi population of China. |
| 18199464 |
Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator) |
| 18214807 |
Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator) |
| 18267032 |
Observational study of gene-disease association. (HuGE Navigator) |
| 18272472 |
Observational study of gene-disease association. (HuGE Navigator) |
| 18320070 |
Observational study of gene-disease association. (HuGE Navigator) |
| 18330515 |
Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator) |
| 18336890 |
Observational study of gene-disease association. (HuGE Navigator) |
| 18347181 |
Observational study of gene-disease association and pharmacogenomic / toxicogenomic. (HuGE Navigator) |
| 18349297 |
Observational study of gene-disease association. (HuGE Navigator) | →View more information from publications. |
Recent Publications on XRCC1: |  |
Polymorphisms in the DNA repair gene XRCC1 and associations with systemic lupus erythematosus risk in the Taiwanese Han Chinese population.
XRCC1 plays a central role in mammalian DNA repair processes. Two... | 3rd November, 2009
| Graduate Institute of Chinese Medical Science, China Medical University,
| Lupus. 2009 Oct 30.
DOI Direct Link |
The Influence of Variations in the DNA Repair (XRCC1) Gene on HIV-1/AIDS among Indian Population.
Genetic polymorphisms in DNA repair genes may influence individual... | 30th October, 2009
| Department of Biotechnology, Panjab University, Chandigarh, India.
| Folia Biol (Praha). 2009;55(5):183-6.
|
Association of Molecular Markers With Toxicity Outcomes in a Randomized Trial of Chemotherapy for Advanced Colorectal Cancer: The FOCUS Trial.
PURPOSE: Predicting efficacy and toxicity could potentially allow... | 28th October, 2009
| Oncology & Clinical Research and Pathology & Tumour Biology Sections,
| J Clin Oncol. 2009 Oct 26.
DOI Direct Link |
Increase the cisplatin cytotoxicity and cisplatin-induced DNA damage in HepG2 cells by XRCC1 abrogation related mechanisms.
Cisplatin is one of the most potent chemotherapeutic anticancer drugs for... | 27th October, 2009
| Department of Occupational Health and Environmental Health, School of
| Toxicol Lett. 2009 Oct 21.
DOI Direct Link |
Optimal function of the DNA repair enzyme TDP1 requires its phosphorylation by ATM and/or DNA-PK.
Human tyrosyl-DNA phosphodiesterase (TDP1) hydrolyzes the phosphodiester... | 24th October, 2009
| Laboratory of Molecular Pharmacology, Center for Cancer Research, National
| EMBO J. 2009 Oct 22.
DOI Direct Link |
→View more research publications. |
XRCC1 results (if any) from reagent suppliers | 
|
Search Bioportfolio and other Life Science Sites for XRCC1,
or search for XRCC1 on BioPortfolio's antibody search engine.
This page has been viewed 1283 times
Recent Search Terms used to find this page: XRCC1 2009 | XRCC1 | xrcc1 | xrcc1 head and neck cancer | what is x-ray repair | XRCC1 | XRCC1 | x ray repair genetic disease | x ray repair genetic disease | .
Resources from the NCBI used on this page, NCBI's standard disclaimer applies.
|
